Overview

Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the safety and tolerability of KW-3902IV and measure its effect on renal function.
Phase:
Phase 2
Details
Lead Sponsor:
NovaCardia, Inc.
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Furosemide
Rolofylline